Skip to content

Funding Boost for EarliTec's Autism Diagnosis Tool

  • $21.5 million Series B led by Nexus NeuroTech Ventures, Venture Investors.
  • Technology employed by eight physicians in six U.S. states.
  • FDA-approved method involves child interaction with short videos.

About 1 in every 36 kids in the United States has autism, if we are to believe the data from CDC. Studies show that the earlier a child is diagnosed, the better their ability to develop is. EarliTec Diagnostics got a new fund to improve their tool of diagnosing children as aged as 16 months already. The FDA-approved method held by the ATL-based startup has a child watching short videos and seeing mild interactions among people on a screen for 12 minutes.

While the device, powered with AI, monitors the child's eyes, detection is carried on out. According to the report of EarliTec, the children with autism do not interact with the video in the same way compared to the children who do not have autism. The funds were raised to back a $21.5 million Series B round led by Nexus NeuroTech Ventures, which invests in companies developing modalities for brain disorders, and Venture Investors, a venture fund in the Midwest that focuses on health care. Presently, the technology offered by the company is employed by eight physicians from six different states in the U.S. Thomas Ressemann, the CEO said that the capital would be used to push back the product commercialization processes.

EarliTec has concentrated on toddlers aged from 16 to 30 months. In the not-too-distant future, a part of this new fund will be used for research intending to widen the age group the current system can identify.

Edited by Shruti Thapa